Therapeutics: BMP and activin membrane-bound inhibitor (BAMBI)

Cancer

INDICATION: Lung cancer; non-small cell lung cancer (NSCLC)

Patient sample, cell culture and mouse studies suggest BAMBI

Read the full 174 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE